{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:22:03Z","timestamp":1769797323501,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10787-025-02037-w","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:53:48Z","timestamp":1763564028000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone modulates cytokine and chemokine secretion by CD4\u2009+\u2009T cells from SSc patients and exerts antifibrotic effects in HOCl-induced SSc mice"],"prefix":"10.1007","volume":"34","author":[{"given":"Maria Eduarda","family":"de Oliveira Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-4320","authenticated-orcid":false,"given":"Anderson Rodrigues","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a Tavares","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Steffani Silva","family":"Florencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Roberta","family":"da Silva Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Henrique","family":"dos Santos Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan Cordeiro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Arnaldo","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Neri","family":"da Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Luzia Branco Pinto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacyr Jesus Barreto","family":"de Melo R\u00eago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelly Cristiny","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira Galdino","family":"da Rocha Pitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3892\/or.2019.7434","volume":"43","author":"F Ai","year":"2020","unstructured":"Ai F, Zhao G, Lv W et al (2020) Dexamethasone induces aberrant macrophage immune function and apoptosis. Oncol Rep 43:427\u2013436. https:\/\/doi.org\/10.3892\/or.2019.7434","journal-title":"Oncol Rep"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.11057","volume":"23","author":"C Bobeica","year":"2021","unstructured":"Bobeica C, Niculet E, Tatu A et al (2021) Old and new therapeutic strategies in systemic sclerosis (Review). Exp Ther Med 23:1\u20136. https:\/\/doi.org\/10.3892\/etm.2021.11057","journal-title":"Exp Ther Med"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.steroids.2017.08.012","volume":"127","author":"AT Dantas","year":"2017","unstructured":"Dantas AT, de Almeida AR, Sampaio MCPD et al (2017) Corticosteroid inhibits chemokines production in systemic sclerosis patients. Steroids 127:24\u201330. https:\/\/doi.org\/10.1016\/j.steroids.2017.08.012","journal-title":"Steroids"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10787-019-00600-w","volume":"27","author":"AR De Almeida","year":"2019","unstructured":"De Almeida AR, Dantas AT, Pereira MC et al (2019) Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients. Inflammopharmacology 27:723\u2013730. https:\/\/doi.org\/10.1007\/s10787-019-00600-w","journal-title":"Inflammopharmacology"},{"key":"2037_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01296-9","author":"AR De Almeida","year":"2023","unstructured":"De Almeida AR, Dantas AT, de Oliveira Gon\u00e7alves ME et al (2023) PPAR\u03b3 partial agonist LPSF\/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-023-01296-9","journal-title":"Inflammopharmacology"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/nejmoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380:2518\u20132528. https:\/\/doi.org\/10.1056\/nejmoa1903076","journal-title":"N Engl J Med"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.40560","volume":"70","author":"A Fern\u00e1ndez-Codina","year":"2018","unstructured":"Fern\u00e1ndez-Codina A, Walker KM, Pope JE (2018) Treatment algorithms for systemic sclerosis according to experts. Arthritis Rheumatol 70:1820\u20131828. https:\/\/doi.org\/10.1002\/art.40560","journal-title":"Arthritis Rheumatol"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/14397595.2016.1270796","volume":"27","author":"M Iudici","year":"2017","unstructured":"Iudici M (2017) What should clinicians know about the use of glucocorticoids in systemic sclerosis? Mod Rheumatol 27:919\u2013923. https:\/\/doi.org\/10.1080\/14397595.2016.1270796","journal-title":"Mod Rheumatol"},{"key":"2037_CR9","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","volume":"10","author":"WY Jia","year":"2022","unstructured":"Jia WY, Zhang JJ (2022) Effects of glucocorticoids on leukocytes: genomic and non-genomic mechanisms. World J Clin Cases 10:7187\u20137194. https:\/\/doi.org\/10.12998\/wjcc.v10.i21.7187","journal-title":"World J Clin Cases"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/art.34534","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian N, Marut W, Servettaz A et al (2012) Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis Rheum 64:3430\u20133440. https:\/\/doi.org\/10.1002\/art.34534","journal-title":"Arthritis Rheum"},{"key":"2037_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.14458","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401\u20131424. https:\/\/doi.org\/10.1111\/jdv.14458","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.17219\/acem\/64334","volume":"26","author":"EJ Kucharz","year":"2017","unstructured":"Kucharz EJ, Kope\u0107-M\u0229drek M (2017) Systemic sclerosis sine scleroderma. Adv Clin Exp Med 26:875\u2013880. https:\/\/doi.org\/10.17219\/acem\/64334","journal-title":"Adv Clin Exp Med"},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.7150\/ijbs.73915","volume":"18","author":"QV Le","year":"2022","unstructured":"Le QV, Wen SY, Chen CJ et al (2022) Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin. Int J Biol Sci 18:6102\u20136113. https:\/\/doi.org\/10.7150\/ijbs.73915","journal-title":"Int J Biol Sci"},{"key":"2037_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7861","author":"L Li","year":"2019","unstructured":"Li L, Li Q, Wei L et al (2019) Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2019.7861","journal-title":"Exp Ther Med"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.004","volume":"190","author":"J Li","year":"2020","unstructured":"Li J, Hua M, Hu X et al (2020) Dexamethasone suppresses the Th17\/1 cell polarization in the CD4+ T cells from patients with primary immune thrombocytopenia. Thromb Res 190:26\u201334. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.004","journal-title":"Thromb Res"},{"key":"2037_CR17","doi-asserted-by":"publisher","first-page":"109465","DOI":"10.1016\/j.intimp.2022.109465","volume":"113","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhang Y, Xu D et al (2022) Long course of low-dose dexamethasone following or after bleomycin administration ameliorates pulmonary fibrosis. Int Immunopharmacol 113:109465. https:\/\/doi.org\/10.1016\/j.intimp.2022.109465","journal-title":"Int Immunopharmacol"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01861","volume":"10","author":"M Meng","year":"2019","unstructured":"Meng M, Tan J, Chen W et al (2019) The fibrosis and immunological features of hypochlorous acid induced mouse model of systemic sclerosis. Front Immunol 10:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2019.01861","journal-title":"Front Immunol"},{"key":"2037_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.humimm.2021.03.009","volume":"82","author":"ME Mohamed","year":"2021","unstructured":"Mohamed ME, Gamal RM, El-Mokhtar MA et al (2021) Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte\/macrophage surface markers: relation to the degree of skin involvement. Hum Immunol 82:634\u2013639. https:\/\/doi.org\/10.1016\/j.humimm.2021.03.009","journal-title":"Hum Immunol"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-47083-y","volume":"13","author":"A Morozan","year":"2023","unstructured":"Morozan A, Joy S, Fujii U et al (2023) Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease. Sci Rep 13:1\u201315. https:\/\/doi.org\/10.1038\/s41598-023-47083-y","journal-title":"Sci Rep"},{"key":"2037_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imm.13125","volume":"159","author":"MC Nielsen","year":"2020","unstructured":"Nielsen MC, Andersen MN, M\u00f8ller HJ (2020) Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro. Immunology 159:63\u201374. https:\/\/doi.org\/10.1111\/imm.13125","journal-title":"Immunology"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/BOR.0000000000000735","volume":"32","author":"C Orvain","year":"2020","unstructured":"Orvain C, Assassi S, Avouac J, Allanore Y (2020) Systemic sclerosis pathogenesis: contribution of recent advances in genetics. Curr Opin Rheumatol 32:505\u2013514. https:\/\/doi.org\/10.1097\/BOR.0000000000000735","journal-title":"Curr Opin Rheumatol"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-9591-2_2","volume":"2020","author":"M Raulf","year":"2019","unstructured":"Raulf M (2019) T cell: primary culture from peripheral blood. Methods Mol Biol 2020:17\u201331. https:\/\/doi.org\/10.1007\/978-1-4939-9591-2_2","journal-title":"Methods Mol Biol"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-42464-9","volume":"13","author":"S Speca","year":"2023","unstructured":"Speca S, Farhat MM, Jendoubi M et al (2023) Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis. Sci Rep 13:1\u201312. https:\/\/doi.org\/10.1038\/s41598-023-42464-9","journal-title":"Sci Rep"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"E19301","DOI":"10.1097\/MD.0000000000019301","volume":"99","author":"K Suga","year":"2020","unstructured":"Suga K, Yamashita H, Takahashi Y et al (2020) Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis. Medicine (Baltimore) 99:E19301. https:\/\/doi.org\/10.1097\/MD.0000000000019301","journal-title":"Medicine (Baltimore)"},{"key":"2037_CR26","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"2037_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/rheumatology\/keab359","volume":"61","author":"C Yang","year":"2022","unstructured":"Yang C, Lei L, Pan J et al (2022) Altered CD4+T cell and cytokine levels in peripheral blood and skin samples from systemic sclerosis patients and IL-35 in CD4+T cell growth. Rheumatology 61:794\u2013805. https:\/\/doi.org\/10.1093\/rheumatology\/keab359","journal-title":"Rheumatology"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-02037-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:03:46Z","timestamp":1769749426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-02037-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-02037-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol that involved collection of blood and clinical data from human beings was evaluated and approved by the ethics committee for research with human beings of the Health Sciences Center of the Universidade Federal de Pernambuco, under CAAE n\u00ba: 58725722.8.0000.5208 and N\u00ba of opinion: 6.314.837. The study protocol involving animals was evaluated and approved by the Ethics Committee on the Use of Animals (CEUA) of the Universidade Federal de Pernambuco, process no 0067\/2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}